National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings, 48965 [05-16575]

Download as PDF Federal Register / Vol. 70, No. 161 / Monday, August 22, 2005 / Notices Democracy Blvd., One Democracy Plaza, Room 1076, MSC 4874, Bethesda, MD 20892– 4874. 301–435–0814. lambert@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health, HHS) Dated: August 15, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–16574 Filed 8–19–05; 8:45 am] BILLING CODE 4140–01–M Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Laurie Friedman Donze, PhD, Scientific Review Administrator, Office of Scientific Review, NCCAM, National Institutes of Health, Suite 401, MSC 5475, 6707 Democracy Blvd., Bethesda, MD 20892, 301–402–1030, donzel@mail.nih.gov. Dated: August 12, 2005. Anthony N. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–16582 Filed 8–19–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Center for Complementary & Alternative Medicine; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel, Training and Education. Date: November 3–4, 2005. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The O’Callaghan Hotel, 174 West Street, Annapolis, MD 21401. Contact Person: Laurie Friedman Donze, PhD, Scientific Review Administrator, Office of Scientific Review, NCCAM, National Institutes of Health, Suite 401, MSC 5475, 6707 Democracy Blvd., Bethesda, MD 20892, 301–402–1030, donzel@mail.nih.gov. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel, Secondary Analysis of Data on CAM Use in Minority Populations. Date: November 15, 2005. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. VerDate jul<14>2003 16:09 Aug 19, 2005 Jkt 205001 Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group, Biomedical Research Review Subcommittee AA–1. Date: October 13–14, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Sathasiva B. Kandasamy, PhD, Scientific Review Administrator, Office of Scientific Affairs, National Institute on Alcohol Abuse & Alcoholism, Extramural Review Branch, 5635 Fishers Lane, Bethesda, MD 20892–9304, (301) 443–2861, skandasa@mail.nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group, Clinical and Treatment Subcommittee AA–3. Date: October 20–21, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Ernestine Vanderveen, PhD, Acting Chief, EPRB, NIH/NIAAA, PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 48965 Extramural Project Review Branch, 5635 Fishers Lane, Room 3039, Office of Extramural Activities, Bethesda, MD 20892– 9304, (301) 443–2531, tvanderv@mail.nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group, Health Services Research Review Subcommittee AA–2. Date: November 2–3, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Select Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Lorraine Gunzerath, PhD, MBA, Scientific Review Administrator, National Institute on Alcohol Abuse & Alcoholism, Office of Scientific Affairs, Extramural Project Review Branch, 5635 Fishers Lane, Room 3043, Bethesda, MD 20892–9304, (301) 443–2369, lgunzera@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Center Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants, National Institutes of Health, HHS) Dated: August 15, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–16575 Filed 8–19–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel, 06–18, Review R21. Date: September 14, 2005. Time: 10 a.m. to 11 a.m. E:\FR\FM\22AUN1.SGM 22AUN1

Agencies

[Federal Register Volume 70, Number 161 (Monday, August 22, 2005)]
[Notices]
[Page 48965]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16575]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Initial Review Group, Biomedical Research Review 
Subcommittee AA-1.
    Date: October 13-14, 2005.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Sathasiva B. Kandasamy, PhD, Scientific Review 
Administrator, Office of Scientific Affairs, National Institute on 
Alcohol Abuse & Alcoholism, Extramural Review Branch, 5635 Fishers 
Lane, Bethesda, MD 20892-9304, (301) 443-2861, 
skandasa@mail.nih.gov.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Initial Review Group, Clinical and Treatment Subcommittee 
AA-3.
    Date: October 20-21, 2005.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Ernestine Vanderveen, PhD, Acting Chief, EPRB, 
NIH/NIAAA, Extramural Project Review Branch, 5635 Fishers Lane, Room 
3039, Office of Extramural Activities, Bethesda, MD 20892-9304, 
(301) 443-2531, tvanderv@mail.nih.gov.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Initial Review Group, Health Services Research Review 
Subcommittee AA-2.
    Date: November 2-3, 2005.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Select Bethesda, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Lorraine Gunzerath, PhD, MBA, Scientific Review 
Administrator, National Institute on Alcohol Abuse & Alcoholism, 
Office of Scientific Affairs, Extramural Project Review Branch, 5635 
Fishers Lane, Room 3043, Bethesda, MD 20892-9304, (301) 443-2369, 
lgunzera@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.271, 
Alcohol Research Center Development Awards for Scientists and 
Clinicians; 93.272, Alcohol National Research Service Awards for 
Research Training; 93.273, Alcohol Research Programs; 93.891, 
Alcohol Research Center Grants, National Institutes of Health, HHS)

    Dated: August 15, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-16575 Filed 8-19-05; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.